These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20880165)

  • 1. Optimizing thiopurine therapy: more weight to the metabolite argument.
    Gibson PR; Gearry RB
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1592-4. PubMed ID: 20880165
    [No Abstract]   [Full Text] [Related]  

  • 2. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
    Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases.
    Dewit O
    Acta Gastroenterol Belg; 2010; 73(3):331-5. PubMed ID: 21086934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of inosine-5'-monophosphate dehydrogenase in thiopurine metabolism in patients with inflammatory bowel disease.
    Haglund S; Vikingsson S; Söderman J; Hindorf U; Grännö C; Danelius M; Coulthard S; Peterson C; Almer S
    Ther Drug Monit; 2011 Apr; 33(2):200-8. PubMed ID: 21311411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
    Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
    Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines.
    Waljee AK; Joyce JC; Wang S; Saxena A; Hart M; Zhu J; Higgins PD
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):143-50. PubMed ID: 19835986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
    Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
    Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease.
    Kennedy NA; Asser TL; Mountifield RE; Doogue MP; Andrews JM; Bampton PA
    Intern Med J; 2013 Mar; 43(3):278-86. PubMed ID: 22946880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiopurine metabolites and the role of thiopurine methyltransferase activity in inflammatory bowel disease.
    Qasim A; Buckley M; O' Morain CA
    Gut; 2002 Jul; 51(1):141; author reply 141-2. PubMed ID: 12077110
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD.
    de Boer NK; van Bodegraven AA; Jharap B; de Graaf P; Mulder CJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):686-94. PubMed ID: 18043678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease.
    Ohtsuka Y; Arai K; Aoyagi Y; Fujii T; Yamakawa Y; Ohtani K; Ikuse T; Baba Y; Inage E; Kudo T; Suzuki R; Nagata S; Shimizu T
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1626-30. PubMed ID: 20880170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurine metabolism monitoring: implications in inflammatory bowel diseases.
    Dewit O; Starkel P; Roblin X
    Eur J Clin Invest; 2010 Nov; 40(11):1037-47. PubMed ID: 20629710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases.
    Schedel J; Gödde A; Schütz E; Bongartz TA; Lang B; Schölmerich J; Müller-Ladner U
    Ann N Y Acad Sci; 2006 Jun; 1069():477-91. PubMed ID: 16855176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
    Banerjee S; Bishop WP
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-thioguanine nucleotides and thiopurine methyltransferase activity: important factors determining response to treatment and incidence of adverse effects from azathioprine and 6-MP.
    George P; Roberts R; Pike L
    N Z Med J; 2003 Jul; 116(1178):U531. PubMed ID: 12901364
    [No Abstract]   [Full Text] [Related]  

  • 18. 6-thioguanine nucleotides and thiopurine methyltransferase activity: important factors determining response to treatment and incidence of adverse effects from azathioprine and 6-MP.
    Gearry R; Barclay M; Gardiner S; Zhang M
    N Z Med J; 2003 Jul; 116(1178):U531. PubMed ID: 12897892
    [No Abstract]   [Full Text] [Related]  

  • 19. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
    Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
    Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to 'The end of the dosage of 6 Thioguanine nucleotides? Not so sure…'.
    Waljee AK; Sauder K; Patel A; Segar S; Zhang Y; Zhu J; Stidham RW; Balis U; Higgins PDR
    J Crohns Colitis; 2018 Jan; 12(1):127. PubMed ID: 29028967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.